Exane Derivatives Baxter International Inc Transaction History

Exane Derivatives

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$63.83 - $80.0 $9,893 - $12,400	-155 Closed	0 $0
Q1 2022 Apr 22, 2022	SELL	$76.85 - $89.45 $1,229 - $1,431	-16 Reduced 9.36%	155 $12,000
Q4 2021 Jan 28, 2022	SELL	$74.57 - $87.19 $3,281 - $3,836	-44 Reduced 20.47%	171 $14,000
Q3 2021 Oct 26, 2021	SELL	$73.77 - $83.61 $506,209 - $573,731	-6,862 Reduced 96.96%	215 $17,000
Q2 2021 Jul 28, 2021	BUY	$80.5 - $88.01 $569,698 - $622,846	7,077 New	7,077 $569,000
Q1 2021 Apr 30, 2021	SELL	$76.38 - $86.03 $604,471 - $680,841	-7,914 Closed	0 $0
Q4 2020 Jan 27, 2021	BUY	$75.39 - $82.36 $349,884 - $382,232	4,641 Added 141.8%	7,914 $635,000
Q3 2020 Oct 06, 2020	SELL	$78.33 - $90.73 $4,621 - $5,353	-59 Reduced 1.77%	3,273 $263,000
Q2 2020 Jul 10, 2020	BUY	$78.66 - $94.14 $261,387 - $312,827	3,323 Added 36922.22%	3,332 $286,000
Q4 2019 Jan 22, 2020	SELL	$76.7 - $88.45 $559,756 - $645,508	-7,298 Reduced 99.88%	9 $0
Q3 2019 Oct 15, 2019	SELL	$81.4 - $89.78 $171,021 - $188,627	-2,101 Reduced 22.33%	7,307 $639,000
Q2 2019 Jul 12, 2019	BUY	$73.44 - $82.41 $690,923 - $775,313	9,408 New	9,408 $0

998

450M

1.97M

3.04M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $17.5B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

Stay updated on Exane Derivatives with notifications on news.